I agree that this site is using cookies. You can find further informations here.
X
Suvannasankha, A.
93  results:
Search for persons X
?
1

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELA..:

Nooka, A. ; Cohen, A. ; Lee, H....
HemaSphere.  7 (2023)  S2 - p. 27-28 , 2023
Link: https://doi.org/10.1097/..
 
?
2

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA..:

van de Donk, N. ; Mateos, M.-V. ; Cohen, Y.C....
HemaSphere.  7 (2023)  S2 - p. 25-26 , 2023
Link: https://doi.org/10.1097/..
 
?
3

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN ..:

Suvannasankha, A. ; Bahlis, N. ; Trudel, S....
HemaSphere.  6 (2022)  - p. 830-831 , 2022
Link: https://doi.org/10.1097/..
 
?
4

Retreatment with ribavirin and interferon alpha 2b of relap..:

Munoz, S. ; Suvannasankha, A. ; DiGregorio, K....
Gastroenterology.  114 (1998)  - p. A1307 , 1998
Link: https://doi.org/10.1016/..
 
?
5

Safety and efficacy of belantamab mafodotin with pembrolizu..:

Suvannasankha, Attaya ; Bahlis, Nizar ; Trudel, Suzanne...
Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
6

1q amplification and PHF19 expressing high-risk cells are a..:

Johnson, Travis S. ; Sudha, Parvathi ; Liu, Enze...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
7

P-240 Efficacy and safety of ciltacabtagene autoleucel in p..:

Cohen, Adam ; Cohen, Yaël ; Suvannasankha, Attaya...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S167-S168 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of cilta-cel in patients with progressi..:

Cohen, Adam D. ; Mateos, María-Victoria ; Cohen, Yael C....
Blood.  141 (2023)  3 - p. 219-230 , 2023
Link: https://doi.org/10.1182/..
 
?
9

P-044 Evaluation of the efficacy and safety of two differen..:

Richter, Joshua ; Bumma, Naresh ; Dhodapkar, Madhav...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S58-S59 , 2023
Link: https://doi.org/10.1016/..
 
?
10

OA-27 Single cell transcriptomics reveals the impact of tum..:

Sudha, Parvathi ; Zaid, Mohammad Abu ; Johnson, Travis...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S16-S17 , 2023
Link: https://doi.org/10.1016/..
 
?
11

OA-32 The impact of genomics to identify novel immunotherap..:

Liu, Enze ; Sudha, Parvathi ; Zaid, Mohammad Abu...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S19-S20 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Identifying novel mechanisms of biallelic TP53 loss refines..:

Liu, Enze ; Sudha, Parvathi ; Becker, Nathan...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Cilta-Cel Efficacy and Safety in Patients with Progressive ..:

Suvannasankha, Attaya ; Mateos, Maria-Victoria ; Cohen, Yael C...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S395-S396 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Single‐agent belantamab mafodotin in patients with relapsed..:

Nooka, Ajay K. ; Cohen, Adam D. ; Lee, Hans C....
Cancer.  129 (2023)  23 - p. 3746-3760 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Nivolumab and daratumumab combination regimens for the trea..:

Abdallah, Al-Ola ; Lesokhin, Alexander ; Wrobel, Tomasz...
Frontiers in Hematology.  2 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15